DE69520111T2 - Schätzung des Fragmentierungsmusters von Kollagen in Körperflüssigkeiten und Diagnose von mit dem Kollagenmetabolismus zusammenhängenden Störungen - Google Patents

Schätzung des Fragmentierungsmusters von Kollagen in Körperflüssigkeiten und Diagnose von mit dem Kollagenmetabolismus zusammenhängenden Störungen

Info

Publication number
DE69520111T2
DE69520111T2 DE69520111T DE69520111T DE69520111T2 DE 69520111 T2 DE69520111 T2 DE 69520111T2 DE 69520111 T DE69520111 T DE 69520111T DE 69520111 T DE69520111 T DE 69520111T DE 69520111 T2 DE69520111 T2 DE 69520111T2
Authority
DE
Germany
Prior art keywords
collagen
body fluids
estimation
diagnosis
disorders related
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69520111T
Other languages
English (en)
Other versions
DE69520111D1 (de
Inventor
Martin Bonde
Per Qvist
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Immunodiagnostic Systems Nordic AS
Original Assignee
Osteometer Biotech AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9506050.5A external-priority patent/GB9506050D0/en
Application filed by Osteometer Biotech AS filed Critical Osteometer Biotech AS
Publication of DE69520111D1 publication Critical patent/DE69520111D1/de
Application granted granted Critical
Publication of DE69520111T2 publication Critical patent/DE69520111T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6887—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from muscle, cartilage or connective tissue
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/10—Musculoskeletal or connective tissue disorders
    • G01N2800/108—Osteoporosis
DE69520111T 1994-10-17 1995-10-16 Schätzung des Fragmentierungsmusters von Kollagen in Körperflüssigkeiten und Diagnose von mit dem Kollagenmetabolismus zusammenhängenden Störungen Expired - Lifetime DE69520111T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DK119494 1994-10-17
GBGB9506050.5A GB9506050D0 (en) 1995-03-24 1995-03-24 Assaying collagen fragments in body fluids
PCT/EP1995/004055 WO1996012193A1 (en) 1994-10-17 1995-10-16 Estimation of the fragmentation pattern of collagen in body fluids and the diagnosis of disorders associated with the metabolism of collagen

Publications (2)

Publication Number Publication Date
DE69520111D1 DE69520111D1 (de) 2001-03-22
DE69520111T2 true DE69520111T2 (de) 2001-09-06

Family

ID=26065366

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69520111T Expired - Lifetime DE69520111T2 (de) 1994-10-17 1995-10-16 Schätzung des Fragmentierungsmusters von Kollagen in Körperflüssigkeiten und Diagnose von mit dem Kollagenmetabolismus zusammenhängenden Störungen

Country Status (8)

Country Link
US (1) US6372442B1 (de)
EP (1) EP0787301B1 (de)
JP (1) JPH10507266A (de)
AT (1) ATE199185T1 (de)
AU (1) AU3746295A (de)
DE (1) DE69520111T2 (de)
ES (1) ES2154739T3 (de)
WO (1) WO1996012193A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5962639A (en) * 1987-11-06 1999-10-05 Washington Research Foundation Synthetic peptides corresponding to telopeptide sequences of cross-linked type I collagen metabolites
US5750647A (en) * 1995-05-19 1998-05-12 Washington Research Foundation Synthetic peptide analogs of NTx
GB9617616D0 (en) 1996-08-22 1996-10-02 Osteometer Biotech As Assaying protein fragments in body fluids
AU5754298A (en) 1996-12-09 1998-07-03 Osteometer Biotech As Sandwich assays for collagen type i fragments
CA2297555A1 (en) * 1997-07-31 1999-02-11 Metra Biosystems, Inc. Collagen-peptide assay method
US6348320B1 (en) 1998-06-19 2002-02-19 Washington Research Foundation Cartilage resorption assays measuring type II collagen fragments
US6602980B1 (en) 1998-06-19 2003-08-05 Washington Research Foundation Collagen type III synthetic peptides for collagen resorption assays
US6916903B2 (en) 1998-06-19 2005-07-12 Washington Research Foundation Collagen type III synthetic peptides for collagen resorption assays
US6255056B1 (en) 1998-06-19 2001-07-03 Washington Research Foundation Cartilage resorption assays
US20050124071A1 (en) * 2003-09-30 2005-06-09 Kraus Virginia B. Methods and compositions for diagnosing musculoskeletal, arthritic and joint disorders by biomarker dating
EP2074428B1 (de) * 2006-09-29 2015-07-01 Roche Diagnostics GmbH Beurteilung des risikos eines fortschreitens der krankheit bei einem patienten mit rheumatoider arthritis

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL6716836A (de) 1967-12-11 1969-06-13
DE2816841A1 (de) 1978-04-18 1979-10-31 Max Planck Gesellschaft Radioimmunologische bestimmung von prokollagen (typ iii) und prokollagen- peptid (typ iii)
DE3209149A1 (de) 1982-03-13 1983-10-06 Hoechst Ag Verfahren zur gemeinsamen immunologischen bestimmung von prokollagen-peptid (typ iii) und prokollagen-peptid col 1 (typ iii) und verfahren zur herstellung von anti-prokollagen-peptid col 1 (typ iii)-serum
CA1251729A (en) 1982-05-19 1989-03-28 Steffen Gay In vitro diagnostic methods using monoclonal antibodies against connective tissue proteins
US4628027A (en) 1982-05-19 1986-12-09 Molecular Engineering Associates, Ltd. Vitro diagnostic methods using monoclonal antibodies against connective tissue proteins
SE8304836D0 (sv) 1983-09-09 1983-09-09 Pharmacia Ab Sett att bestemma forendringar i ledbrosk
US5001225A (en) 1986-12-08 1991-03-19 Georgetown University Monoclonal antibodies to a pan-malarial antigen
US5679583A (en) 1987-05-02 1997-10-21 Hoechst Aktiengesellschaft Monoclonal antibodies for the selective immunological determination of intact procollagen peptide (type III) and procollagen (type III) in body fluids
DE3714634A1 (de) 1987-05-02 1988-11-17 Hoechst Ag Verfahren zur selektiven immunologischen bestimmung von intaktem prokollagen peptid (typ iii) und prokollagen (typ iii) in koerperfluessigkeiten und mittel zu dessen durchfuehrung
GB2205643B (en) 1987-05-08 1991-03-13 Farmos Group Limited Type iii collagen degradation assay
US5320970A (en) 1987-11-06 1994-06-14 Washington Research Foundation Detection of collagen degradation in vivo
US5300434A (en) 1987-11-06 1994-04-05 Washington Research Foundation Hybridoma cell line producing an antibody to type-I collagen amino-terminal telopeptide
US5962639A (en) 1987-11-06 1999-10-05 Washington Research Foundation Synthetic peptides corresponding to telopeptide sequences of cross-linked type I collagen metabolites
US4973666A (en) * 1987-11-06 1990-11-27 Washington Research Foundation Peptide fragments containing HP and LP cross-links
ATE115963T1 (de) 1988-04-27 1995-01-15 Hoechst Ag Monoklonaler antikörper zur selektiven immunologischen bestimmung von intaktem prokollagen peptid (typ iii) und prokollagen (typ iii) in körperflüssigkeiten.
GB8815174D0 (en) 1988-06-25 1988-08-03 Rowett Research Inst Method of monitoring collagen degradation
EP0439545A4 (en) 1988-10-24 1991-10-23 Bruce Caterson Methods of and compositions for diagnosing, monitoring and treating the early stages of osteosarthritis
WO1990008195A1 (en) 1989-01-13 1990-07-26 President And Fellows Of Harvard College Monoclonal antibody to human type ix collagen
ZA909755B (en) 1989-12-07 1991-09-25 Res Dev Foundation Cell cycle-dependent regulation of phosphorylation of the human retinoblastoma gene product
GB9014220D0 (en) 1990-06-26 1990-08-15 Farmos Yhtymy Oy Method for the immunlolgical determinition of the carboxyterminal propeptide of type i procollagen
GB9105893D0 (en) * 1991-03-20 1991-05-08 Orion Yhtymae Oy Bone resorption assay based on a peptide liberated during collagen degradation
DE4225038C2 (de) * 1992-07-29 1995-11-30 Boehringer Mannheim Gmbh Herstellung und Verwendung von Antikörpern gegen Kollagen
WO1994014844A1 (en) * 1992-12-28 1994-07-07 Baylink David J Bone resorption assay
JP2703116B2 (ja) 1993-07-28 1998-01-26 ベーリンガー マンハイム ゲーエムベーハー コラーゲンまたはコラーゲン断片を検出するためのイムノアッセイ
DK104093D0 (da) * 1993-09-17 1993-09-17 Osteometer A S Fremgangsmaade til bestemmelse af collagen-fragmenter i legemsvaesker, test-kit og midler til udoevelse af fremgangsmaaden og anvendelse af fremgangsmaaden til diagnosticering af lidelser associeret til collagen-metabolismen
US6110689A (en) * 1994-01-21 2000-08-29 Osteometer A/S Method of assaying collagen fragments in body fluids, a test kit and means for carrying out the method and use of the method to diagnose the presence of disorders associated with the metabolism of collagen
GB9506050D0 (en) 1995-03-24 1995-05-10 Osteometer A S Assaying collagen fragments in body fluids
US5763272A (en) 1994-12-23 1998-06-09 Boehringer Mannheim Gmbh Hybridoma for producing antibody for collagen I
DE59505585D1 (de) 1994-12-23 1999-05-12 Roche Diagnostics Gmbh Antigene und Antikörper zum Nachweis von Kollagen I

Also Published As

Publication number Publication date
JPH10507266A (ja) 1998-07-14
ES2154739T3 (es) 2001-04-16
EP0787301B1 (de) 2001-02-14
US6372442B1 (en) 2002-04-16
DE69520111D1 (de) 2001-03-22
AU3746295A (en) 1996-05-06
WO1996012193A1 (en) 1996-04-25
EP0787301A1 (de) 1997-08-06
ATE199185T1 (de) 2001-02-15

Similar Documents

Publication Publication Date Title
DE69520111T2 (de) Schätzung des Fragmentierungsmusters von Kollagen in Körperflüssigkeiten und Diagnose von mit dem Kollagenmetabolismus zusammenhängenden Störungen
DE69718592D1 (de) Multioperationsverfahren für die ausführung von explorations- und/oder entwicklungsbohrungen im offshore-bereich
ATE241139T1 (de) Vorrichtung zur durchführung eines oder mehrerer kompetitiver immunoassays
DE69126248D1 (de) Immunchromatographischer assay und verfahren zur nutzung desselben
DE3853057T2 (de) Entfernbare endoarterielle-Vorrichtung, bestimmt für die Reparatur von Ablösungen in arteriellen Wänden.
DK557089D0 (da) Proeve for type iii collagennedbrydning
ATE347697T1 (de) Methode zur bestimmung von proteinfragmenten in körperflüssigkeiten
DE69003650T2 (de) Aloewasser, Herstellungsverfahren und Mittel, die dieses enthalten.
DE68917613T2 (de) Natriumdecylsulfat enthaltende Waschlösung, Testsatz und Verfahren zur Bestimmung eines immunologischen Liganden.
DE69725606D1 (de) Methoden für die diagnose von allergischen atemwegsaspergillosen
ATE179712T1 (de) Analoge für spezifische oligosaccharid-protein- wechselwirkungen und ihre verwendungen
WO2001016184A3 (en) Diagnostic assay for type 2 heparin-induced thrombocytopenia
DE3789477T2 (de) Vorrichtung für Anwendung in der Kanalisation von Blutgefässen.
ATE48037T1 (de) Verfahren und reagenz zur verwendung zur bestimmung von pivka-ii.
DE69606600T2 (de) Heizbarer, 90 Grad Ventilblock mit unüblicher Ventilanordnung für Differenzdrucktransmitter
FR2607896B1 (fr) Valve de pression differentielle
DE69013854T2 (de) Ventil für T-Abzweigung.
DE3780315D1 (de) Antigen-antikoerperkomplex und methoden zur anwendung.
DE69731388D1 (de) Nukleinsäure-fragmente, die spezifische für die mitglieder des m. tuberculosis komplexes sind, deren anwendung zur detektion und differentiale diagnose der mitglieder des m. tuberculosis komplexes
DE68922846T2 (de) Enzymimmuntest für menschliches typiv-collagen gemäss dem sandwichverfahren.
DE69027393T2 (de) Dichtung für Fluide
CA2202913A1 (en) Antibody reagent for detecting dissecting aortic aneurysm and uses thereof
DE69009098D1 (de) Dichtheitsprüfverfahren von Behältern für Waren, insbesondere lose Zerealien.
DE3574600D1 (de) Unsymmetrische 1:2-chromkomplexfarbstoffe.
DE69004522D1 (de) Entlastungsventil für hydraulische Kreisläufe.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition